Literature DB >> 3548473

The prevention of renal impairment in patients undergoing orthotopic liver grafting by infusion of low dose dopamine.

R J Polson, G R Park, M J Lindop, J V Farman, R Y Calne, R Williams.   

Abstract

Administration of low dose dopamine (2.0 micrograms/kg/minute) begun before surgery in patients undergoing liver transplantation decreases the incidence of postoperative renal impairment. Thirty-four consecutive patients in the Cambridge/King's College Hospital liver transplantation series were studied. Nineteen patients (21 transplant operations) received prophylactic low dose dopamine throughout the operative and early postoperative period, while 15 patients (15 transplant operations) received dopamine only when clinically indicated for incipient renal failure or as an inotropic agent. In the prophylactic dopamine group, only two transplant operations (9.5%) were complicated by renal impairment, whereas in the other group, 10 patients (67%) developed renal impairment (p = 0.001); of these, four developed acute renal failure (27%). Comparison of seven pairs of patients, matched for age, sex, diagnosis, operative blood loss and operative hypotension (one group receiving dopamine, the other not), revealed a significantly higher urine output in the first 24 hours and creatinine clearance 24-48 hours after surgery (p less than 0.05) in those treated prophylactically. In view of these findings, we would recommend that consideration be given to the prophylactic use of dopamine in patients undergoing orthotopic liver transplantation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3548473     DOI: 10.1111/j.1365-2044.1987.tb02938.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  9 in total

Review 1.  Can the use of low-dose dopamine for treatment of acute renal failure be justified?

Authors:  C J Burton; C R Tomson
Journal:  Postgrad Med J       Date:  1999-05       Impact factor: 2.401

2.  Dopaminergic agents in vital organ perfusion.

Authors:  J L Vincent
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

3.  The mortality of abdominal aortic aneurysm.

Authors:  R J Polson; G R Park
Journal:  Ann R Coll Surg Engl       Date:  1987-05       Impact factor: 1.891

Review 4.  An evaluation of pharmacological strategies for the prevention and treatment of acute renal failure.

Authors:  M K Dishart; J A Kellum
Journal:  Drugs       Date:  2000-01       Impact factor: 9.546

5.  Pharmacokinetics of pancuronium in patients undergoing coronary artery surgery with and without low dose dopamine.

Authors:  J M Wierda; P J van der Starre; A H Scaf; W D Kloppenburg; J H Proost; S Agoston
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

6.  Dopexamine hydrochloride, a novel drug with renal vasodilator properties: two case studies.

Authors:  A R Bodenham; G R Park
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

Review 7.  The altered pharmacokinetics and pharmacodynamics of drugs commonly used in critically ill patients.

Authors:  A Bodenham; M P Shelly; G R Park
Journal:  Clin Pharmacokinet       Date:  1988-06       Impact factor: 6.447

8.  Blood concentrations of dopexamine in patients during and after orthotopic liver transplantation.

Authors:  P A Gray; T Jones; G R Park
Journal:  Br J Clin Pharmacol       Date:  1994-01       Impact factor: 4.335

9.  The use of diuretics and dopamine in acute renal failure: a systematic review of the evidence.

Authors: 
Journal:  Crit Care       Date:  1997       Impact factor: 9.097

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.